Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (211-220 of 443) with videos related to

Pageof 45
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITDGaëlle Labouré, Stéphanie Dulucq, Myriam Labopin, et al.
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Transplantation and Cellular Therapy|April 8, 2021
Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic LeukemiaBhagirathbhai Dholaria, Myriam Labopin, Emanuele Angelucci, et al.
Cancer|January 9, 2019
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and overNicole Santoro, Myriam Labopin, Fabio Ciceri, et al.
American Journal of Hematology|January 1, 2019
Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantationCatherine J Lee, Myriam Labopin, Dietrich Beelen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2018
Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationThomas Heinicke, Myriam Labopin, Christoph Schmid, et al.
Clinical Hematology International|October 1, 2021
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: <i>In vivo</i> T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant StudyAli Bazarbachi, Myriam Labopin, Giorgia Battipaglia, et al.
Journal of Hematology & Oncology|May 8, 2020
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMTJaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemiaHélène Lapillonne, Aline Renneville, Anne Auvrignon, et al.
JAMA Oncology|July 14, 2018
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia RelapseMohamed A Kharfan-Dabaja, Myriam Labopin, Emmanuelle Polge, et al.
Pageof 45

Showing results (211-220 of 443) with videos related to

Sort By:
Pageof 45
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITDGaëlle Labouré, Stéphanie Dulucq, Myriam Labopin, et al.
Leukemia|June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemiaJonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
Transplantation and Cellular Therapy|April 8, 2021
Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic LeukemiaBhagirathbhai Dholaria, Myriam Labopin, Emanuele Angelucci, et al.
Cancer|January 9, 2019
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and overNicole Santoro, Myriam Labopin, Fabio Ciceri, et al.
American Journal of Hematology|January 1, 2019
Comparative outcomes of myeloablative and reduced-intensity conditioning allogeneic hematopoietic cell transplantation for therapy-related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantationCatherine J Lee, Myriam Labopin, Dietrich Beelen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2018
Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationThomas Heinicke, Myriam Labopin, Christoph Schmid, et al.
Clinical Hematology International|October 1, 2021
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: <i>In vivo</i> T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant StudyAli Bazarbachi, Myriam Labopin, Giorgia Battipaglia, et al.
Journal of Hematology & Oncology|May 8, 2020
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMTJaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemiaHélène Lapillonne, Aline Renneville, Anne Auvrignon, et al.
JAMA Oncology|July 14, 2018
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia RelapseMohamed A Kharfan-Dabaja, Myriam Labopin, Emmanuelle Polge, et al.
Pageof 45